Cytek Biosciences (CTKB) Other Non-Current Assets (2020 - 2026)

Cytek Biosciences (CTKB) has 7 years of Other Non-Current Assets data on file, last reported at $6.3 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets rose 37.87% year-over-year to $6.3 million; the trailing twelve-month figure through Mar 2026 stood at $6.3 million (up 37.87% YoY), and the FY2025 full-year result was $6.7 million, up 23017.24% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $6.3 million, down from $6.7 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $6.7 million in Q4 2025 and bottomed at $29000.0 in Q4 2024.
• The 5-year median for Other Non-Current Assets is $3.0 million (2023), against an average of $3.1 million.
• The widest annual swing landed in 2024, when Other Non-Current Assets tumbled 99.0%; it then surged 23017.24% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $2.9 million in 2022, then slumped by 88.58% to $331000.0 in 2023, then slumped by 91.24% to $29000.0 in 2024, then soared by 23017.24% to $6.7 million in 2025, then decreased by 5.94% to $6.3 million in 2026.
• The last three Other Non-Current Assets figures came in at $6.3 million (Q1 2026), $6.7 million (Q4 2025), and $4.5 million (Q3 2025), per Business Quant data.

Peer Comparison